4SC-201 (Resminostat) in Advanced Colorectal Carcinoma
Ontology highlight
ABSTRACT: The purpose of this study is to determine the Maximum Tolerated Dose (MTD) of 4SC-201 (Resminostat) in combination with FOLFIRI and whether 4SC-201 (Resminostat) is effective and safe in combination FOLFIRI versus FOLFIRI alone in the treatment of advanced colorectal carcinoma.
DISEASE(S): Colorectal Carcinoma,Advanced Or Metastasized Colorectal Carcinoma,Carcinoma,Advanced Colorectal Carcinoma,Colorectal Neoplasms
PROVIDER: 2100868 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA